Simplify Asset Management Inc. Acquires 36,337 Shares of Danaher Corporation $DHR

Simplify Asset Management Inc. boosted its holdings in shares of Danaher Corporation (NYSE:DHR) by 449.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 44,416 shares of the conglomerate’s stock after purchasing an additional 36,337 shares during the quarter. Danaher comprises 0.2% of Simplify Asset Management Inc.’s portfolio, making the stock its 23rd biggest holding. Simplify Asset Management Inc.’s holdings in Danaher were worth $10,168,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. JPL Wealth Management LLC bought a new stake in Danaher during the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC bought a new stake in Danaher during the 4th quarter valued at approximately $26,000. WFA of San Diego LLC bought a new stake in Danaher during the 2nd quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd bought a new stake in Danaher in the 3rd quarter worth approximately $27,000. Finally, Financial Life Planners bought a new stake in Danaher in the 3rd quarter worth approximately $32,000. Institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.1%

Shares of DHR opened at $172.12 on Monday. The company has a market cap of $121.82 billion, a PE ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81. The business has a fifty day moving average of $183.52 and a 200 day moving average of $208.70. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The company had revenue of $5.95 billion during the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.Danaher’s revenue was up 3.7% on a year-over-year basis. During the same period last year, the company earned $1.88 earnings per share. On average, sell-side analysts expect that Danaher Corporation will post 8.43 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Rothschild & Co Redburn set a $205.00 price objective on Danaher in a research note on Friday, April 17th. UBS Group reduced their price objective on Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Barclays reduced their price objective on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. The Goldman Sachs Group reduced their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Finally, Wall Street Zen downgraded Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $238.65.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.